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HUMAN LABORATORY ANIMALS: MARTYRS
FOR MEDICINE
MARIAN F. RATNOFF* & JUSTIN C. SMITH**
0  N December 3, 1967, doctors in a Capetown hospital opened a man's
chest, removed his heart and replaced it with the heart of an individual
recently pronounced dead.1 Few happenings in medicine have so captured
the interest of the public or aroused as many conflicting emotions as the
rash of heart transplants which have occurred in the past few months. The
press has begun to raise moral and ethical questions about the new
procedures.' This current interest attracts attention to the larger problem
of human experimentation, an issue in which lawyers will become in-
creasingly involved. A delineation of the ethical and legal rights of
individuals who, willingly or not, serve society by being laboratory
animals is of critical importance.
Contemporary interest in the ethics of human experimentation began in
1947.' Stunned by the trial record in United States v. Karl Brandt,4
which recounted medical experiments of doubtful importance, doctors
and lawyers involved in the Nuremberg Trials promulgated a code of
behavior to guide medical researchers torn by sometimes conflicting desires
to conquer disease and at the same time to respect the integrity of the in-
dividual patient. The product of that medical-legal collaboration, the
Nuremberg Code,5 was admirable in intent, but has been criticized as be-
* Member of the Ohio Bar.
** Profesor of Law, Texas Technological College.
1. An Unexpected Difficulty, Details of Heart Transplant Reported, 202 J.A.M.A. No.
12, at 23 (Dec. 18, 1967).
2. See, e.g., Time, Jan. 19, 1968, at 50-51.
3. For an excellent discussion of the interrogation of former Nazi leaders held in the
Nuremberg Prison following the cessation of hostilities in 1946, including the work of Dr.
Professor Hurt of the Strassburg Anatomical Institute see, Musmanno, Witness Against
Eichman, Averbach & Price, The Verdicts Were Just 89 (1966).
4. 1 & 2 Trials of War Criminals Before the Nuremberg Military Tribunals Under
Control Council Law No. 10 (1949).
5. 2 id. at 181-82. The Nuremberg Code states:
1. The voluntary consent of the human subject is absolutely essential....
2. The experiment should be such as to yield fruitful results for the good of society,
unprocurable by other methods or means of study, and not random and un-
necessary in nature.
3. The experiment should be so designed and based on the results of animal experi-
mentation and a knowledge of the natural history of the disease or other problem
under study that the anticipated results will justify the performance of the ex-
periment
4. The experiment should be so conducted as to avoid all unnecessary physical and
mental suffering and injury.
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ing at once too restrictive and too ambiguous in language to provide sig-
nificant and workable guidelines. 6 Furthermore, it did not address itself
to the need for the advancement of medicine.
The imprecisions of that Code may be due to the fact that people, par-
ticularly attorneys, dislike discussions of the problems of human experi-
mentation. Their reticence may reflect an appreciation of the risks of
exposing ethical questions which are not easily answered by the meta-
physician, let alone by the legal scholar working within the confines of
established precedent. The problem is compounded by the tendency of
doctors and lawyers to view the problem in fundamentally different ways.
Law tends to build on experience, while medicine uses experience only as a
guide for the evolution of new ways to deal with unsolved problems. Put
another way, a lawyer works from society to his client, while the physi-
cian works through his patient upon society. The legal community must
free medical research to proceed, without permitting abridgement of the
legal rights of the patients.
The purpose of this paper is to examine, for the benefit of lawyers, the
moral and legal dilemmas faced by doctors-a problem more discussed in
medical and scientific journals than legal ones-and to describe some of
the attempts of the medical community to deal with the conflict which
arises when the good of society and the good of the individual clash.
5. No experiment should be conducted when there is an a priori reason to believe that
death or disabling injury will occur; except, perhaps, in those experiments where
the experimental physicians also serve as subjects.
6. The degree of risk to be taken should never exceed that determined by the
humanitarian importance of the problem to be solved by the experiment.
7. Proper preparations should be made and adequate facilities provided to protect tile
experimental subject against even remote possibilities of injury, disability, or
death.
8. The experiment should be conducted only by scientifically qualified persons. The
highest degree of skill and care should be required through all stages of the ex-
periment of those who conduct or engage in the experiment.
9. During the course of the experiment the human subject should be at liberty to
bring the experiment to an end if he has reached the physical or mental state
where continuation of the experiment seems to him to be impossible.
10. During the course of the experiment the scientist in charge must be prepared to
terminate the experiment at any stage, if he has probable cause to believe, in
the exercise of the good faith, superior skill and careful judgment required of him
that a continuation of the experiment is likely to result in injury, disability, or
death to the experimental subject.
6. See, e.g., Beecher, Some Fallacies and Errors in the Application of the Principle of
Consent in Human Experimentation, 3 Clinical Pharmacology and Therapeutics 141 (1962)
(editorial); Welt, Reflections on the Problems of Human Experimentation, 25 Connecticut
Medicine 75 (1961).
MEDICAL TREATMENT AND RESEARCH
Hopefully this paper will help foster the "interchange between law and
medicine" called for by a recent writer.7
I. Tia PHENOMENON OF MEDICAL RESEARCH
Until recently, medical research was a semi-private affair, conducted
by lone investigators supported by individual patrons or foundations
interested in health problems. Since World War II, however, medical re-
search has become institutionalized in a way difficult for the layman to
understand. The end of the war marked the entrance of the federal gov-
ernment into medical laboratories and the beginning of a program as
accepted a part of social welfare as is social security. Since that time,
much of the progress of American medical science has become an exten-
sion of national policy. One writer's explanation of the phenomenon is
probably accurate:
The extraordinary growth of the federal role in medical research had as its base a
historical confluence of forces in the post-war period. First the "payoffs" from research
in the physical sciences during the war-radar, the Bomb-gave basic research new
respectability in political circles. Second, the end of the war left the nation with
unemployed scientists and more money. Third, the medical societies concerned with
specific diseases such as polio and cancer were taken over from the doctors by civilians
and turned toward promotion to raise money and educate the public.b
Currently, even on an international level, American advances in the
field of medicine have become part of our foreign policy. This country has
undertaken to improve public health in underdeveloped countries through
our knowledge of vaccines, nutrition and sanitation. President Johnson's
offer of contraceptive information and supplies to overpopulated nations
is but one recent example of the extent to which medicine and medical
researchers are being employed by the government.
The American people have not been unaffected by the involvement of
their government in medicine. One has only to note the use of the word
"research" today as a noun, adjective and verb. The virtual isolation and
obscurity in which medical research formerly functioned have been shat-
tered. Newspapers abound with material on heart and kidney transplants,
wonder drugs and miraculous vaccines and serums. The public, through
its broad financial support of organizations like the American Heart Asso-
ciation and the American Cancer Society, demonstrates its faith that
doctors will "find the way." But at the same time, a curious change in the
public's attitude is clearly discernible. On a recent television program, a
minister commenting upon the heart transplants used the following
7. Freund, Ethical Problems in Human Experimentation, 273 New England J.
Med. 687 (1965); Freund on Human Experimentation, id. at 774 (editorial).
8. Drew, The Health Syndicate/Washington's Noble Conspirators, The Atlantic, Dec.
1967, at 75.
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words: "I think we have to be very careful about what we are doing. We
must maintain the life of the patient."9 The inference of these words
seems clear. They indicate that the public is now looking over the doctor's
shoulder. Before the public becomes too free with its advice, it must real-
ize that the effectiveness of the new procedures has been bought at a
price; the inevitable cost is the inescapable risk to those on whom the
innovations were first tried.
II. THE DEFINITION OF HUMAN EXPERIMENTATION
In a sense, every time a doctor elects a course of treatment for his pa-
tient, a human experiment takes place; no matter how routine a particu-
lar treatment may be, the individual reactions of patients are unpredicta-
ble. What is beneficial for one may be disastrous for another. The law
recognizes this variability of response among individuals. Thus, a physi-
cian who has exercised reasonable care in treating a patient is protected
by the classical tort test of "the standard practice."'1 Under this doctrine,
he will not be liable for an honest mistake in judgment or for an untoward
reaction by the patient to accepted therapy." Ironically, this same legal
standard can be a hindrance to the development of new procedures, new
techniques and new drugs. Although it is the duty of a physician to keep
up with the advancements made by his profession, he must not forge too
far ahead. 2 For the physician, the admonition of Alexander Pope, "Be
not the first by whom the new are tried/Nor yet the last to cast the old
aside"' 3 is a puzzling reality.
A. Differentiation between Therapeutic and Manipulative Experiments
Obviously, some physicians must move away from the established drug
or practice. One physician had to be the first to undertake an organ trans-
plant. In this regard, two types of innovation must be distinguished-those
experiments designed for the treatment or cure of a particular person,
who is the patient-subject of the experiment, and those experiments de-
signed to add to our understanding of normal and abnormal functioning
of the body, including the effect of drugs and various techniques. This
second type of research, in which the subject has ordinarily nothing to
gain either diagnostically or therapeutically, creates the principal prob-
lem and the one which concerns us here. Ideally, such experiments are
conducted upon volunteers and are ordinarily carried out with the sub-
9. City Camera News, Station WJW-TV, CBS Affiliate, Cleveland, Ohio, Jan. 11, 1968,
11 P.M. E.S.T. (emphasis added).
10. W. Prosser, Torts 166 (3d ed. 1955) [hereinafter referred to as Prosser].
11. Id. at 165.
12. 41 Am. Jur. Physicians & Surgeons § 86 (1942).
13. A. Pope, Essay on Criticism, pt. II, 11. 132-33.
[Vol. 3 6
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ject's express consent with a view to advancing the state of medical
knowledge. In this second type of experiment lies the nub of the moral
issue. As Dr. Walsh McDermott has put it: "When the needs of society
come in head-on conflict with the rights of an individual, someone has to
play God."' 4 Most medical scientists would shrink from such a role, but
the moral issues they must face are certainly not commonplace. Most
physicians begin with the question of whether an experiment, dangerous
or potentially lethal for the subject, should be performed because the
benefit to so many will be so great. Theoretically, the answer should be
easy for the physician whose Hippocratic Oath 5 requires him to strive
for his patient. This principle of dedication to the individual rather than
society is not alien to the law.' 6
B. Individual Questions of Morality
Despite these sentiments, to which a majority of lawyers and doctors
would heartily subscribe, it is naive to believe that medical triumph can
be secured without life-threatening risk to individuals. Assuming the med-
ical scientist has satisfied himself that although the risk to his subject
exists, he acts with the subject's full and knowing acquiesence, his task is
not over. There remains the question of whether the experiment seeks an
answer which will serve humanity or only academic curiosity. An experi-
ment encompassing grave risk in return for an answer not honestly needed
is one described by Dr. Henry Beecher, a professor at Harvard Medical
School.'" In the criticized study, an examination of the toxic effects upon
the blood of an antibiotic, chloramphenicol, was undertaken. Although a
well known complication of the use of the drug is severe and often fatal
aplastic anemia,18 the stated aim of the study was to define further the
toxicology of chloramphenicol.' 9 In this study of 41 patients who did not
require the drug for their own therapy, 20 developed toxic symptoms
14. McDermott, Opening Comments, 67 Annals of Internal Medicine, Supp. 7, at 39
(1967).
15. The Hippocratic Oath, reprinted in F. Garrison, History of Medicine 102 (4th ed.
1929).
16. It is noteworthy that over the years the law has never seen fit to justify the taking
of one or more lives in order to preserve the lives of others. Perhaps this is best exemplified
by the holding of the English court in The Queen v. Dudley, 14 Q.B.D. 273 (1884), one of
the two lifeboat cases, and United States v. Holmes, 26 F. Cas. 360 (E.D. Pa. 1842), the
American counter-part decided some years earlier. The rule in the latter case is said to have
prompted Justice Cardozo to comment that there is no law of human jettison.
17. Beecher, Ethics and Clinical Research, 274 New England J. Med. 1354 (1966).
18. Scott, Cartwright & Wintrobe, Acquired Aplastic Anemia: An Analysis of Thirty-nine
Cases and Review of the Pertinent Literature, 38 Medicine 119 (1959).
19. Beecher, supra note 17, at 1357.
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after its administration. Beecher and those sharing his concern21 are,
however, not without vocal and competent critics.
A further question is whether an adequate theoretical basis exists for
the proposed undertaking, derived from sound, established knowledge.
Often, in the scientist's anxiety to accomplish his goal, his actions may be
too hastily conceived. Sometimes the help gained from a careful study of
animal models may not yet be available, but the investigator, conscious of
his mission, proceeds with his human studies nonetheless. Typical of such
a situation is the current vogue for heart transplantation, daring in con-
cept, magnificent in skill, but undertaken at a stage in knowledge about
immunity which is inadequate to afford most patients the protection
needed against rejection of the donated organ.2
A final question concerns the practicality of the experiment. Can it be
designed to give a reasonable answer, considering safety, time, expense
and the possibility that the observation can be made without bias? Typi-
cal of this problem is the continuing medical controversy over the role of
anticoagulant drugs in the treatment of patients who have suffered heart
attacks..23 Since the anticipated benefit of treatment is small, medical in-
vestigators have had to rely on data obtained from many patients. The
inevitable variations in the quality of medical care and accuracy of ob-
servations has brought about confusion. A clear answer comes only when
the question can be posed in such a way that relatively few subjects need
to be studied. Unfortunately, as in the case of anticoagulant therapy, the
uncertainties of diagnosis and the vagueness with which therapeutic re-
sults can be judged have made it difficult to pose the simple question of
practicability.24
III. THE MEDICAL VIEW OF THE PROBLEM: THE CODE PERIOD:
1947-1967
Researchers tackling these moral decisions have not lacked guidance
from their profession. Doctors as a group maintain a rigid inter-profes-
sional discipline in order to insure the adequacy of patient care.
Since the days of the Greeks, doctors have sworn aloud: "I will follow
that method of treatment which according to my ability and judgment I
20. Id.
21. M. Pappwortb, Human Guinea Pigs: Experimentation on Man (1967). For
criticism of Beecher, see, e.g., Medical World News, April 9, 1965, at 43.
22. See, e.g., Rusk, Organ Transplant, N.Y. Times, Jan. 14, 1968, at 86, col. 1; The
Heart: Miracle in Cape Town, Newsweek, Dec. 18, 1967, at 86; Heart Transplants: Treat-
ment or Experiment, 159 Science 374 (1968) (letter to the editor).
23. Merskey & Drapkin, Analytic Review: Anticoagulant Therapy, 25 Blood 567
(1965).
24. Id.
[Vol. 36
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consider for the benefit of my patients and will abstain from whatever is
deleterious and mischievous." The Hippocratic Oath thus articulates the
morality of Western medicine2 ' and provides the touchstone for all ex-
pressions of medical ethics.
A. Medical Codes of Ethics
In 1803, an English doctor formulated a statement of "Medical Ethics"
upon which was modeled the first code of ethics promulgated by the
American Medical Association in 1848-.20 During the next hundred years,
the medical profession expressed itself formally and informally on the
proper conduct of the physician.27 In contrast to physicians in the United
States, apparently a somewhat liberal attitude prevailed on the European
continent. "Americans who studied at Vienna, Leipzig, and other medical
centers in Europe before the first world war admired the skill of the
doctors but were shocked at treatment administered and operations
performed which would never have been undertaken had the welfare of
the patient been the sole consideration. 28
It was not until the Nuremberg Code was enunciated in 1947 that a
modern-day expression of the ethics of medical experimentation was artic-
ulated. Numerous attempts have been made since the Nuremberg Code to
develop other workable codes of ethics. In 1957, the American Medical
Association, which had issued a formal statement, Principles of Medical
Ethics, expanded it to make it applicable to the research situation.' The
Law Department of the American Medical Association advised its mem-
bers:
In order to avoid legal liability for use of experimental procedures in treatment of a
patient, the following requirements must not vary too radically from the accepted
methods of procedure; and (3) usual and accepted procedures must have been tried
previously without success. Medical ethics prohibit human experimentation except
(1) with the voluntary informed consent of the person on whom the eperiment is
to be performed; (2) after the danger of the experiment has been investigated pre-
viously by animal experimentation; and (3) under proper medical protection and
management.3
0
In 1963, the Medical Research Council to Parliament made an official
statement on responsibility in investigations in human subjects." Finally,
25. Beecher, Experimentation on Man, 169 J.A.MA. 461 (1959).
26. Id.
27. Id.
28. Kidd, The Problem of Experimentation on Human Beings: Limits of the Right of
a Person to Consent to Experimentation on Himself, 117 Science 211, 212 (1953).
29. A.A., Principles of Medical Ethics (1957) (pamphlet).
30. Id.
31. Responsibility in Investigations on Human Subjects, 2 Brit. Medical J. 178, 179
(1964).
1968]
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in 1964, the World Medical Association issued the Declaration of Hel-
sinki:
3 2
DECLARATION OF HELSINKI
RECOmMENDATIONS GUIDING DOCTORS IN CLINICAL RESEARCir
It is the mission of the doctor to safeguard the health of the people. His knowledge
and conscience are dedicated to the fulfillment of this mission.
The Declaration of Geneva of the World Medical Association binds the doctor with
the words, "The health of my patient will be my first consideration"; and the Inter-
national Code of Medical Ethics which declares that "Any act or advice which could
weaken physical or mental resistance of a human being may be used only in his inter-
est."
Because it is essential that the results of laboratory experiments be applied to human
beings to further scientific knowledge and to help suffering humanity, the World Medi-
cal Association has prepared the following recommendations as a guide to each doctor
in clinical research. It must be stressed that the standards as drafted are only a guide
to physicians all over the world. Doctors are not relieved from criminal, civil and
ethical responsibilities under the laws of their own countries.
In the field of clinical research a fundamental distinction must be recognized between
clinical research in which the aim is essentially therapeutic for a patient, and
clinical research the essential object of which is purely scientific and without thera-
peutic value to the person subjected to the research.
I. Basic Principles
1. Clinical research must conform to the moral and scientific principles that justify
medical research, and should be based on laboratory and animal experiments or
other scientifically established facts.
2. Clinical research should be conducted only by scientifically qualified persons and
under the supervision of a qualified medical man.
3. Clinical research cannot legitimately be carried out unless the importance of the
objective is in proportion to the inherent risk to the subject.
4. Every clinical research project should be preceded by careful assessment of in-
herent risks in comparison to foreseeable benefits to the subject or to others.
5. Special caution should be exercised by the doctor in performing clinical research
in which the personality of the subject is liable to be altered by drugs or experi-
mental procedure.
II. Clinical Research Combined With Professional Care
1. In the treatment of the sick person the doctor must be free to use a new thera-
peutic measure if in his judgment it offers hope of saving life, re-establishing
health, or alleviating suffering.
If at all possible, consistent with patient psychology, the doctor should obtain the
patient's freely given consent after the patient has been given a full explanation.
In case of legal incapacity consent should also be procured from the legal
guardian; in case of physical incapacity the permission of the legal guardian
replaces that of the patient.
32. 67 Annals of Internal Medicine, Supp. 7, at 74-75 (1967) (emphasis added).
[Vol. 36
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2. The doctor can combine clinical research with professional care, the objective
being the acquisition of new medical knowledge, only to the extent that clinical
research is justified by its therapeutic value for the patient.
iII. Non-Therapeutic Clinical Research
1. In the purely scientific application of clinical research carried out on a human
being it is the duty of the doctor to remain the protector of the life and health
of that person on whom clinical research is being carried out.
2. The nature, the purpose, and the risk of clinical research must be explained to
the subject by the doctor.
3a. Clinical research on a human being cannot be undertaken without his free con-
sent, after he has been fully informed; if he is legally incompetent the consent of
the legal guardian should be procured.
b. The subject of clinical research should be in such a mental, physical, and legal
state as to be able to exercise fully his power of choice.
3c. Consent should as a rule be obtained in writing. However, the responsibility for
clinical research always remains with the research worker; it never falls on the
subject, even after consent is obtained.
4a. The investigator must respect the right of each individual to safeguard his
personal integrity, especially if the subject is in a dependent relationship to
the investigator.
4b. At any time during the course of clinical research the subject or his guardian
should be free to withdraw permission for research to be continued. The investi-
gator or the investigating team should discontinue the research if in his or their
judgment, it may, if continued, be harmful to the individual.
Of all the codes, this Declaration is the most significant because it
was adopted in 1967 by at least nine 6lite medical societies in this
country.3 In their endorsement of the Declaration, these medical bodies
noted that its principles of medical ethics supplemented ethics to which
every American physician already subscribes." The American Medical
Association endorsed the Declaration but issued additional guidelines
enlarging on the fundamental concepts3 5
B. The Essence of the Codes
Almost all official pronouncements and commentaries state unequivo-
cally that human experimentation must be preceded by animal experi-
mentation. These declarations also pose such questions as: will the pro-
posed trial meaningfully advance the state of medical knowledge? Is the
danger to which the investigator submits the patient-subject commen-
surate with the benefit which might ensue to him, or is the danger so
minimal that the investigator may ask him to accept it although no per-
sonal benefit is foreseen? Is the patient-subject fully informed and has
he given his fully voluntary consent?
33. Id. at 75.
34. Id.
35. Id. at 76.
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It is significant that none of the declarations speak to any form of
control by groups other than doctors and scientists. The possibility that
lay control may be imposed upon medical research workers could cause
much apprehension to physicians.
C. Interdisciplinary Help for Doctors
In addition to formal guidelines, doctors often seek prior approval for
their proposed studies from colleagues. Informal consultation with other
research scientists and formal review committees (which exist in most
medical schools) are two methods of exploring the efficiency of a con-
templated experiment. More and more the investigator is advised to seek
guidance from medical school department heads or from the editors of
medical journals.30 Often scientific journals will refuse to publish reports
of research which appears to be immoral or hazardous to the subjects."
In addition, most research scientists belong to specialized societies which
pass informal judgment upon the ethics of work presented at society
meetings, as well as upon the merits of the study. Medical scientists as
a group, like lawyers, are strongly self-disciplining.
IV. THE LEGAL VIEW OF THE PROBLEM
Tracing the legal history of medical experimentation has been the
work of Ladimer 8 All writers in this field are indebted to him for his
difficult work in gathering source material. Many of the materials in
the next two sections can be found in their entirety in his anthology on
the subject of clinical investigation."0
Historically, the law has dealt harshly with the medical experimenter.
Although physicians had been experimenting with man and other animals
for centuries,"0 there was an absence of decisional law on experimentation
until the eighteenth century. In 1767, one Slater brought suit against a
surgeon and an apothecary for undertaking to rebreak his improperly
36. Responsibility in Investigation on Human Subjects, 2 Brit. Medical J. 178, 179
(1964); Ladimer, Social Responsibility in Clinical Investigation, Medical Sci., Oct. 1967,
at 33.
37. Letter from Dr. Russell Elkington, Editor, Annals of Internal Medicine, to the
author.
38. See, e.g., Ladimer, Ethical and Legal Aspects of Medical Research on Human
Beings, 3 J. Pub. L. 467 (1954). Ladimer, Human Experimentation: Medicolegal Aspects,
257 New England J. Med. 18 (1959); Ladimer, Medical Experimentation: Legal Con-
siderations, 1 Clinical Pharmacology and Therapeutics 674 (1960).
39. Clinical Investigation in Medicine: Legal, Ethical, and Moral Aspects (I. Ladimer
& R. Newman ed. 1963).
40. It was the practice in ancient times for the king to hand over condemned criminals
for experimental purposes in science. Later the Ptolemies did the same in Egypt. Beecher,
Experimentation in Man, 169 JAX.M.A. 461 (1959).
[Vol. 36
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healed leg and attempting to straighten it by attaching a claw of iron
to hold the bone in place."- Most legal scholars invoke this case as the
first expression of the legal maxim that experimentation is at the physi-
cian's peril. 2 Concluding that the treatment was a rash action, the King's
Bench said, "It seems as if Mr. Baker wanted to try an experiment with
this new instrument."4 The case specifically addressed the problem of
consent: "It is reasonable that a patient should be told what is about
to be done to him . . . ."' In view of the crucial nature of consent in
medical experimentation, the old English judges seemed prescient.
A. The Physician's Peril Doctrine
Scattered early American cases speak of the perils of departure from
the accepted mode of practice,4 5 but the American counterpart of Slater
did not appear until 100 years later in Carpenter v. Blake .4 Blake used
an untried method to set Carpenter's elbow. The court held it "incumbent
on surgeons called to treat such an injury, to conform to the system
. established; and if they depart from it, they do it at their peril.""
American cases following Carpenter reinforced the doctor's peril prin-
ciple. These cases present vignettes of quackery, leaving little doubt as
to why the courts held steadfastly to their prejudice against experiment-
ing. Witness the plight of a young man who in 1911 presented himself at
the Dr. Pratt Institute for the purposes of having his smallpox scars
removed. Noting that the treatment proved to be more disfiguring than
the defect which it sought to cure, the court held that the defendant
should have known the treatment was not sanctioned by medical science
and that therefore the doctors had no right to perform the procedure."5
In Kershaw v. Tilbury," a nine-year-old girl suffered permanent
damage because the defendant-physician, using a radio diagnostic
machine of his own invention diagnosed her ailment as meningitis and
caused a delay in securing proper treatment for her true illness, osteomye-
litis.
Typically, these cases involved some radical departure from the ac-
41. Slater v. Baker, 95 Eng. Rep. 860 (K.B. 1767).
42. See, e.g., Ladimer, Ethical and Legal Aspects of Medical Research on Human Beings,
3 J. Pub. L. 467 (1954).
43. Slater v. Baker, 95 Eng. Rep. 860, 862 (K.B. 1767).
44. Id.
45. E.g., Landon v. Humphrey, 9 Conn. 209 (1832).
46. 60 Barb. 488 (N.Y. 1871), rev'd on other grounds, 50 N.Y. 696 (1872).
47. Id. at 514.
48. Graham v. Dr. Pratt Institute, 163 Ill. App. 91 (1911).
49. 214 Cal. 679, 8 P.2d 109 (1932).
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cepted standard in the community. They were branded by the courts as
experimentation, but they appear to have been simple instances of
quackery." Very often, the fact situations presented breaches of well-
recognized legal duties, such as want of knowledge and skill, failure to
conform to an established school of medicine, or departure from ac-
cepted practice. Much of the confusion which permeates this area is
directly attributable to the fact that medical research as we know it today
did n6t exist 100 years ago when our courts were preoccupied with de-
fining the liability of a physician to his patient. It is unfortunate that
the judges of this period chose the word "research" when in reality what
they meant to describe were either ill-considered innovations or devia-
tions from standard practices.
B. Legal Recognition of the Necessity for Experimentation
Not until the 1930's and the introduction of the sulfonamides did the
courts begin to take a less jaundiced view of untried procedure and to
show an appreciation of the necessity for trial. Fortner v. Koch" recog-
nized, albeit in dictum, that "if the general practice of medicine and
surgery is to progress, there must be a certain amount of experimenta-
tion carried on .... "I2 But once again there was the admonition to the
doctor not to stray too far.
C. The Development of the Consent Doctrine
Significantly, the cases which helped to build the law's chariness of
experimentation were concerned with the problem of therapeutic innova-
tion directed toward the patient's own disease. Attention must be drawn
to another factor developing along with the physician's peril doctrine,
which on occasion altered the intransigence of the courts. This was the
concept of consent. "[The] Anglo-American law starts with the premise
[that] ... each man is considered to be master of his own body .... Ws
Logically extended, this concept of self-determination leads to the
premise that a man may give his consent to any act which may affect
his body, although it can be shown that this conclusion is not wholly
true. Many of the earlier cases, especially those dealing with malpractice
suits against surgeons, addressed this problem of consent.54 It has always
been possible to give consent sufficiently general in its terms to cover
50. Ladimer, Ethical and Legal Aspects of Medical Research on Human Beings, 3 J.
Pub. L. 467, 479 (1954); see also notes 53-56 infra.
51. 272 Mich. 273, 282, 261 N.W. 762, 765 (1935).
52. Id. at 282, 261 N.W. at 765.
53. Annot., 79 A.L.R.2d 1028 (1961).
54. Smith, Antecedent Grounds of Liability in the Practice of Surgery, 14 Rocky Mt.
L. Rev. 233 (1942).
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the particular operation or authorize a surgeon to do whatever he must
to remedy what he finds. 5 Such a policy, in the absence of blatant mal-
practice, might protect the therapeutic innovator, but in the past failure
to obtain proper consent rendered a surgeon liable in assault and battery,
even in the absence of negligence." Furthermore, the patient could at-
tach conditions to his consent, 7 or tie the hands of a surgeon even in
the face of an emergency. 58 Once again, the legal admonitions of this
period did not cover the physician's liability for innovation not related
to patient care.
D. Consent by Parents for Minors
A unique situation involving both the consent of parent and minor
presented itself in the case of Bonner v. Moran." Here for the first time,
in 1941, was a "case of a surgical operation not for the benefit of the per-
son operated on but for another... ."I' Further, its involved technique re-
quired a mature mind to understand precisely what the donor was offer-
ing to give. Fifteen-year-old Bonner consented to the removal of a large
flap of skin from his side to provide a skin graft for his cousin. The boy
was hospitalized for three months, suffering great pain and disfigurement.
His mother, living in a different city, unaware that the boy had given
consent to the operation, later ratified his consent. The court nevertheless
held the physician liable for proceeding on the child's consent alone,
judging him incapable of understanding the consequences of his act.
The court rejected the view of the Restatement which allows consent
by an intelligent, informed, older minor, and relied on the common law
view that only parental consent is effective."'
In practice, despite the Restatement's stand, hospitals more often than
not require consent of the parents before any treatment is undertaken,
except in demonstrated emergencies.0 -
In 1956, a case arose in which the hospital had parental consent to
the treatment of a minor but was reluctant to proceed.' Doctors at the
Peter Bent Brigham Hospital in Boston contemplated the performance
55. Prosser 104-06.
56. Smith, supra note 54, at 234.
57. Rolater v. Strain, 39 Okla. 572, 137 P. 96 (1913).
58. Mulloy v. Hop Sang, [1935] 1 W.W.R. 714 (Sup. Ct. Alta.).
59. 126 F.2d 121 (D.C. Cir. 1941).
60. Id. at 123.
61. Id. at 122, citing Restatement of Torts § 59 (1934).
62. See Prosser 104.
63. Munsden v. Harrison, No. 68651 Eq., Mass. Sup. Jud. Ct. June 12, 1957; Huskey v.
Harrison, No. 68666 Eq., Mass. Sup. Jud. Ct., Aug. 30, 1957; Foster v. Harrison, No. 68674
Eq., Mass. Sup. uc. Ct., Nov. 20, 1957, reported in Curran, A Problem of Consent:
Kidney Transplantation in Minors, 34 N.Y.U.L. Rev. 891 (1959).
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of the first kidney transplant in identical twins, one of whom faced
certain death from severe renal disease. 4 Hospital officials were uncertain
that even the parents' fully informed consent was legally effective for
such a dangerous and novel proceeding. Disturbed over the moral arid
legal dilemma, the Hospital sought a declaratory judgment from the
Massachusetts Supreme Judicial Court before performing the contem-
plated transplant. 5 Testimony from the parents and the donor-twin led
the court to conclude that everyone concerned was fully aware of the
hazardous nature of the operation. In this and two subsequent transplant
cases, the Massachusetts court relied heavily upon testimony from psy-
chiatrists that a brutal emotional blow would fall upon the healthy twin
if he refused to donate his kidney and his ailing twin's death was
hastened by the refusal. Finding in the psychiatrist's testimony a basis
for a benefit to the healthy child, the court assented to the operations.00
E. Consent by the Incompetent
Many physicians feel that even with full and knowing parental con-
sent the use of minors is never justified. 7 Beecher's condemnation 8 con-
tains several frightening examples of the use of children as experimental
subjects. Many doctors have stated categorically that minors, the aged,
the debilitated, the weak and the incompetent should never be used as
experimental subjects.
The most recent case involving such consent is Hyman v. Jewish
Chronic Disease Hospital.9 The litigation arose when doctors injected
living cancer cells into "volunteer" patients at a New York hospital,
as part of an experiment to determine the existence of inherent im-
muffity to cancer. A lay director of the hospital, learning of the experi-
ment, enlisted the aid of the courts to compel the hospital to give him
access to patients' charts in order to determine whether the patients had
given intelligent consent. The director found it necessary to take his
plea through three courts before his inspection rights as a corporate
director were held superior to the physician-patient privilege which the
hospital invoked.70 Hyman is the first case to touch the right of doctors
to perform experiments not for the immediate benefit to the patient
but rather for the advancement of medical knowledge.
64. Id. at 892.
65. Id.
66. Id. at 893.
67. Gross, The Doctors 312 (1966).
68. Beecher, Ethics and Clinical Research, 274 New Eng. J. Med. 1354, 1356-58 (1966).
69. 15 N.Y.2d 317, 206 N.E.2d 338, 258 N.Y.S.2d 397 (1965).
70. Hyman v. Jewish Chronic Disease Hosp., 42 Misc. 2d 427, 248 N.Y.S.2d 245 (Sup.
Ct.), rev'd, 21 App. Div. 2d 495, 251 N.Y.S.2d 818 (2d Dep't 1964), rev'd, 15 N.Y.2d
317, 206 N.E.2d 338, 258 N.Y.S.2d 397 (1965).
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In deciding Hyman on appeal, the New York Court of Appeals avoided
the question of the impropriety of the experiments. Since that court re-
fused to speak to this issue, the New York Board of Regents, the
licensing authority for doctors in the State of New York, had to face it
directly. The Board both disciplined the doctors 7' involved in the ex-
periment and issued an opinion addressing the question of what form
actual consent must take and "how far . . . the physician . . . [may]
exercise his physician's authority when he is acting in the role of experi-
menter .... ,,72 As one writer points out, the pronouncements by the
Board of Regents, although "not legal precedents .. represent a major
attempt to put some precision into the vague ethical concepts now govern-
ing experimentation with human subjects." 73
V. STATUTES AND REGULATIONS AFFECTING THE USE
OF THE HUMAN VOLUNTEER
In actual practice, certain groups have attempted more than vague
pronouncements on medical experimentation. Notably, where prisoners
and soldiers have been experimental subjects, those responsible for their
care have attempted to formulate workable guidelines.
A. Prisoner Regidations
During World War II, federal and state convicts were used in many
experimental studies on malaria, hepatitis, blood substitutes and new
drugs. 4 Cancer ihjections of the type given to the patients in the Hyman
case were first given to prisoners at the Ohio State Penitentiary." In 1948
an advisory committee to the governor of Illinois set forth guiding
principles for the selection of prisoner-volunteers.7 These regulations
required consent of the subject and absence of coercion. The experiment
also had to yield results unprocurable by other methods of study, and be
necessary for the good of society." Although the regulations attempted
to be specific, such concepts as the "good of society" lead to ambiguities.
A recent article on the use of prisoners for medical research in Iowa
sets forth a procedure followed there.78 When the researcher decides upon
71. The order of the Board of Regents suspended the license of these physicians for one
year, but execution was suspended because the doctors were first offenders and they were
placed on probation. Langer, Human Experimentation: New York Verdict Affirms Patient's
Rights, 151 Science 663 (1966).
72. Id.
73. Id.
74. Beecher, Experimentation in Man, 169 J.A.M.A. 461, 465 (1959).
75. Langer, Human Experimentation: Cancer Studies at Sloan-Kettering Stir Public
Debate on Medical Ethics, 143 Science 551 (1964).
76. Ethics Governing the Service of Prisoners as Subjects in Medical Experiments, 136
J.A.M.A. 447 (1948).
77. Id.
78. Hodges & Bean, The Use of Prisoners for Medical Research, 202 J-KM.A. 513 (1967).
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a project, his proposal is submitted for approval to a research committee
at his medical school. The dean of the medical school then communicates
with the director of penal institutions in the Board of Control of the state
who sends a message about the proposed work to the warden of the
prison. After the warden explains the type of study to be conducted to
the group of volunteers, the prison authorities select men who are not
emotionally ill, habitually unreliable or otherwise unsuited.71
B. Army Regulations
Since the days of Walter Reed and his investigation of the etiology
of yellow fever, the United States Army has used soldier volunteers, and
therefore has very specific regulations dealing with the use of the medi-
cal volunteer.80 The regulations are applicable all over the world, wher-
ever an Army research program is conducted, and extend to all volunteers,
military and civilian. The Army requires that "certain basic principles
be observed to satisfy moral, ethical and legal concepts."81 Consent is
required to be in writing and approved through channels to the Secretary
of the Army.
In the case of the civilian volunteer, provision is made for claims to
be submitted to the Bureau of Employee Compensation, United States
Department of Labor, if disability or death results from participation
in experimental studies. 2
An opinion of the Judge Advocate General accompanies the regulation
setting forth legal implications of volunteer programs. Under the present
laws, "no additional rights against the Government will result from the
death or disability of military and civilian personnel participating in
experiments by reason of the hazardous nature of the operations."8 To
assure that there is no ulterior motivation to seek compensation it is the
policy of the Government to prohibit acceptance of gratuitous services
when they may provide a basis of future claims against the Government. 4
Where the Army contracts out research and development, the Judge
Advocate General has stated that the contractor's employees may prose-
cute claims under the Federal Tort Claims Act.8"
In 1964, the Department of the Army issued additional regulations
concerning the use of investigational drugs, i.e., any substances intended
79. Id. at 514.
80. See Research and Development, Use of Volunteers as Subjects of Research, Dep't of
the Army, A.R. 70-25 (Washington, March 26, 1962).
81. Id.
82. Id. at 3.
83. Id. at 4 (Appendix, Legal Implications).
84. 31 U.S.C. § 665(b) (1964).
85. A.R. 70-25, supra note 80, Appendix at 4.
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to affect the structure and function of the human body." The Army
reiterated the necessity for securing the understanding of the subject
to whom a drug is to be administered. When the purpose of administer-
ing an investigational drug is not to benefit the individual, approval for
its use must be secured by the up-through-channels method described
in a preceding paragraph. "Benefit to the individual is defined as the
administration of a drug to an individual expected to result in the diag-
nosis, mitigation, treatment, cure, or prevention of disease or injury of
the same individual. 87 The Air Force has similar regulations on the
use of investigational drugs."8
C. United States Public Health Regulations
One other governmental agency, the United States Public Health
Service, has seen fit to adopt guidelines for dealing with human subjects.
In 1966, the United States Public Health Service's National Institute of
Health spent $1,248,000,000 to support medical research conducted by
laboratories in medical schools and hospitals throughout the country. 9
Strict compliance with Public Health Service requirements is a pre-
requisite for continued support for meritorious research. It is particularly
significant, therefore, that the Public Health Service has adopted the
essence of the Nuremberg Code9' as a guide to be followed in conducting
experiments involving human subjects. In addition, applications for funds
from the Public Health Service must contain a "statement of assurance"
with words such as: "The investigations encompassed by this application
have been or will be approved by a committee of associates of the in-
vestigator in accordance with the institution's assurance on clinical re-
search."9
1
D. The Investigational Drug Amendment: An Application
to the Food and Drug Act
The first statute to protect the general public was promulgated in
1962.92 The drug amendments to the Federal Food, Drug and Cosmetic
86. Clinical Use of Investigational Drugs, Dep't of the Army, A.R. 40-7 (Washington,
Nov. 13, 1964).
87. Id. at 3.
88. A.F.R. 169-6 (Washington, 10 Apr. 1963), cited in Hartman, Human Volunteers in
Biomedical Research, 130 il. Med. 674, 676 (1965).
89. Washington News, 196 J.A.M.A. 27 (1966).
90. Hartman, supra note 88, at 678; News in Brief, 153 Science 401 (1966).
91. Administration Report, Division of Research Grants, National Institutes of Health,
U.S. Public Health Service, Washington, 1966.
92. Hearings on S. 1552 Before the Senate Comm. on the judiciary, S. Rep. No. 1744,
87th Cong., 2d Sess. (1962).
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Act 93 were enacted in response to the thalidomide tragedy. 4 They con-
cern investigational drugs, not experimental medical or surgical proce-
dures or tests.
Through the device of the "Statement of the Investigator" 0 the clini-
cian is made subject to the requirements of the Investigational Drug
Regulations. He agrees that the investigation will be conducted by him
or under his supervision, that he will keep adequate records of the use of
the drug and return any unused supply, that he will prepare and main-
tain accurate and adequate records and give immediate notice of any
alarming adverse effects, and that he will make available on request
to authorized scientific personnel of the FDA certain records.10 The
signed statement of the investigator requires him to outline the plan of
the experiment, the clinical uses of the drug, the kind of clinical observa-
tions and laboratory tests to be undertaken.9 7 This plan must be amended
if a significant change in the direction of the investigation occurs. 8 Under
the 1962 amendments, as well as later amendments, 0 an investigator
must certify to the Department of Health, Education and Welfare that
he "will inform any human beings to whom such drugs, or any controls
used in connection therewith, are being administered ... that such drugs
are being used for investigational purposes and will obtain the consent
of such human beings or their representatives, except where [he]
deem [s] it not feasible or, in his professional judgment, contrary to the
best interests of such human beings." 00 This provision of the law has
aroused sharp comment.' 0 ' Critics ask the purpose of requiring elaborate
supervisory mechanisms within the bill when the consent provisions give
the investigator such a comfortable leeway. 102 One answer may be that
consent is obviously difficult to define and would seem to vary from
In 1900, a physician-senator attempted to promulgate legislation which would regulate
the use of human beings as experimental subjects. The legislation was conceived for the
benefit of citizens in Washington, D.C., and is described in Ladimer, supra note 42, at
497-98.
93. Federal Food, Drug and Cosmetic Act § 505, as amended, 21 U.S.C. § 355 (Supp.
III, 1967).
94. Note, Drug Liability, 16 W. Res. L. Rev. 392 (1965).
95. Statement of Investigator, Form F.D. 1573, 21 C.F.R. § 130.3 (1967).
96. Id.
97. Id.
98. Id.
99. Federal Food, Drug and Cosmetic Act § 505(i), 21 U.S.C. § 355(i) (Supp. III,
1967).
100. Id. (emphasis added).
101. See, e.g., Boyer, Medical Liability in Drug Trials, 270 New Eng. J. Med. 777 (1964);
Schreiner, Limb to Limbo-The Moral and Legal Entanglement of the Clinical Investigator,
11 Clinical Research 127, 130 (1965).
102. Informed Consent in Drug Research, 3 Colum. J.L. & Soc. Probs. 54 (1966).
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situation to situation. In the Hyman case, the doctors did not tell the
patients they were receiving cancer cells because in their professional
judgment they felt the information would needlessly frighten the
patients, and that it would therefore not have been in the best interests
of the patients to tell them. 3 Since the injection of cancer cells did not
constitute use of an investigational drug, the Food and Drug Act amend-
ments would not have been relevant in any case.
E. Municipal Regulation
One municipal pronouncement on human experimentation speaks with
the utmost clarity but seemingly curtails research."' A 1949 directive
of the Department of Hospitals, City of New York, interdicted clinical
and laboratory research using a patient in any municipal hospital unless
a specific benefit to the patient was involved.105 The directive required
further that any "proposed clinical or laboratory investigations in any
hospital or institution ... be submitted for review and approval by the
Executive Committee of the Medical Board of the hospital concerned.""0
New York has always exhibited militant concern for the rights of pa-
tients in its hospitals. 107 In light of this, it might not be an unreasonable
prediction that as a result of the Hyman case, New York lawmakers will
attempt to promulgate state legislation much like the 1949 municipal
directive. The "sensational charges and accusations" which appeared in
New York newspaper accounts' of the Hyman imbroglio portends wide
public support for such legislation.
VI. CONSENT: THE PIVOTAL ISSUE
A. Legal Precedent
Beecher has pointed out that the most obvious flaw of all the codes is
that they start out with the bland assumption that a patient's consent
can be secured by the doctor just for the asking.10 9 Neither in medicine
nor in law is consent a simple issue. The fundamental premise of Anglo-
American law that each man is the master of his own body is expressed
in the equally venerable common law principle-volenti non fit injuria.
103. Langer, supra note 75, at 552.
104. New York City Dep't of Hosps., General Order 462, Concerning Research Pro-
posals, Oct. 27, 1949, cited in Beecher, supra note 25, at 478 n. 23.
105. Id.
106. Id.
107. See, e.g., Hyman v. Jewish Chronic Disease Hosp., 15 N.Y.2d 317, 206 N.E.2d
338, 258 N.Y.S2d 397 (1965); Munzer v. State, 41 N.Y.S.2d 98 (Ct. Cl. 1943).
108. Langer, supra note 75.
109. Beecher, Consent in Clinical Experimentation: Myth and Reality, 19S J.A.Mk.A. 34
(1966).
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Prosser comments that where no public interest is involved the courts
have been willing to accept the maxim and have left each man free to
work out his own destiny within its framework." 0 Thus, consent would
seem to negate the wrongful element of the defendant's act in inten-
tionally invading the plaintiff's interest."' We know nonetheless that an
individual really cannot consent to a serious harm. Even in the rowdy
days of 1693, an English court believed that mutual consent had its
limits: "'If a man licence [sic] Another to beat him, such licence
[sic] is void as it is against the peace.' ,152 In this country, a person can-
not give legal consent to his own death;" 8 indeed, in England an at-
tempted suicide is a criminal act." 4 In most states, consent to abortion
will not bar an action against the doctor who performs it.", A 1904
court summed up the general feeling on the subject by pointing out that
the state has a direct interest in the lives and health of all its citizens.'
Consequently, the investigator not only owes that person a duty but he
has an obligation to the state to use care and to do nothing that will en-
danger the lives and health of its citizens." 7
B. Religious Views on Consent
The Catholic Church, recognizing that "sometimes medical research
must work on its immediate object, the living man in the interest of
science,"" 8 has taken a strong stand on consent in contradiction to the
"every man is the master of his body" maxim. Pope Pius XII reasoned:
"[T]he doctor can take no measure or try no course of action without
the consent of the patient. . . . On his side, the patient cannot confer
rights he does not possess. . . . As for the patient, he is not absolute
master of himself, of his body or of his soul .... Because he is a user and
not a proprietor he does not have unlimited power to destroy or mutilate
his body and its functions."11
9
A Protestant has said: "A person can prudently permit a few limited
110. Prosser 102.
111. Id.
112. Matthew v. Ollerton, (1693) Comberbach 218, cited in Bohlen, Consent as Affecting
Civil Liability for Breaches of the Peace, 24 Colum. L. Rev. 819, 825 (1924).
113. Kidd, Limits of the Right of a Person to Consent to Experimentation on Himself,
117 Science 211, 212 (1953).
114. Roxburgh, Experiments on Human Subjects, 3 Med. Sci. & L. 132, 135-36 (1963).
115. George, Current Abortion Laws: Proposals and Movements for Reform, 17 W.
Res. L. Rev. 371, 375-84 (1965).
116. Spead v. Tomlinson, 73 N.H. 46, 59 A. 376 (1904).
117. Id.
118. Symposium, Human Experimentation-a World Problem From the Standpoint of
Spiritual Leaders, 7 World Med. J. 80 (1960).
. 119. Id.
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experiments upon himself after a careful study of all elements involved,
that is, the avoidance of too great imprudence, with previous and suffi-
cient animal experiments in order to reduce the risks to a minimum."'n2
In sum, "[T]he moral and spiritual competence of the doctor remains
the most important factor."'*'
A Jewish view realizes that "a certain element of experimentation is
inherent in every medical activity... "I In securing the patient's con-
sent, "the doctor-investigator has to take into consideration not only
the attitude of the individual and his capacity to grasp the meaning of
what is being asked of him but also the general attitude of the group,
the social community and even the nation to which the volunteers be-
long."
C. Informed Consent
One article has said that informed consent presupposes that permission
has been fully granted and that the party who consents to medical proce-
dure is aware of some of the consequences of the treatment.' 4 In dis-
cussing treatment, the article states: "Where possible, disclosure of the
information on which consent is based should precede treatment by
enough time so that the patient or person giving consent has time to
ponder possible alternative courses of action. Further, informed consent
should result from a deliberation based on objective disclosure of the
situation as viewed by the physician."'" Other legal writers have sought
to discuss gradations of consent. Informed consent can be measured by
the assurance that the patient completely understands the contemplated
procedure, that he acknowledges in writing the risks involved and that
he has had explained to him the various possible complications.'20
No matter how carefully legal scholars may delineate the elements of
informed consent, there still remains the problem of how to protect
the volunteer against the subtle forms of coercion of which even the
most benevolent doctor or lawyer may be unaware. A medical student,
for example, may give his fully informed consent to an experiment
through a desire to please his professor or worse, a subtle fear that failure
to consent will influence his professional future. Although prisoners are
120. de Senardens, id. at 81.
121. Id. at 82 (emphasis omitted).
122. Groen, id. at 83.
123. Id.
124. Smith & Schroeder, Legally Effective Consent for the Physician, 32 Postgraduate
Med, Dec. 1962, at A-42, A-44.
125. Id.
126. Cady, Medicolegal Facets of Clinical Experimentation, 31 G.P. Feb. 1965, at 187,
188-89.
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repeatedly told that volunteering for medical experiments will in no
way influence their privileges, how are we to say that there still does
not exist the hope that a parole board might conclude that the volunteer
has paid his debt to society?
Furthermore, there is the inescapable provision of the drug amend-
ments to the Food and Drug Act that the doctor must secure the consent
of the subject-if it is feasible to do so. Very often in performing experi-
ments of a psychological nature, it is extremely important that the sub-
ject not know he is part of an experiment.
The law allows the physician treating a fatally ill patient to refrain
from making a full disclosure of his condition to the patient, if the
doctor feels it is in the best interests of the patient to be silent. Such in-
consistencies in the law make it very difficult to formulate legal guidance
for the physician-investigator. Might not a doctor argue that disclosure
is not always in the best interest of the patient? It is clear that if the law
is to help, it must formulate new doctrines. The old concepts of malprac-
tice and negligence appear to be only partially relevant.
VII. CONCLUSION
The dilemma is simply this: presupposing broad public support for
medical research, should medical advances be treated on a piecemeal
basis, or should legislative bodies come forth at this time and define the
parameters of acceptable experimentation? It appears that society stands
at the hinge of time and that private decisions, while appropriate in
some areas, are not entirely adequate in others. The Nuremberg Code,
the Declaration of Helsinki, and the recommendations of the Medical
Research Council of Parliament provide a framework for broad public
discussions and suggest a need for enlightened attitudes on the part of the
general public, particularly the law, if society is to benefit from the recent
advances in experimental medicine.
